Christina Kay

2020

In 2020, Christina Kay earned a total compensation of $229.6K as Co, Chief Executive Officer at Integrated Biopharma, a 12% increase compared to previous year.

Compensation breakdown

Option Awards$6,125
Salary$215,461
Other$8,000
Total$229,586

Kay received $215.5K in salary, accounting for 94% of the total pay in 2020.

Kay also received $6.1K in option awards and $8K in other compensation.

Rankings

In 2020, Christina Kay's compensation ranked 12,470th out of 13,090 executives tracked by ExecPay. In other words, Kay earned more than 4.7% of executives.

ClassificationRankingPercentile
All
12,470
out of 13,090
5th
Division
Manufacturing
5,348
out of 5,618
5th
Major group
Chemicals And Allied Products
2,165
out of 2,251
4th
Industry group
Drugs
1,880
out of 1,951
4th
Industry
Pharmaceutical Preparations
1,400
out of 1,456
4th
Source: SEC filing on October 27, 2021.

Kay's colleagues

We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2020.

2020

Dina Masi

Integrated Biopharma

Chief Financial Officer

2020

EGerald Kay

Integrated Biopharma

Chairman

2020

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

News

You may also like